Market Assessment for an interface between the nervous system and ML-based digital computation to enable nervous system repair and augmentation.

我们开发了ANIMO，用于调制和观察的自适应神经植入物。ANIMO是一种在神经系统中植入我们专有的机器学习和神经调节技术的容器，以解释神经活动并使用电神经刺激做出反应。我们的目标是部署ANIMO作为兽医保健中不受控制的癫痫发作的解决方案。该设备适用于超过250万名药物难治性候选人，预计手术成本为1万美元，存在数十亿美元的潜在市场。仅考虑药物难治性癫痫的保险病例（估计约占病例的2.5%）时，潜在的可寻址市场规模为7.2亿美元。我们与加拿大最先进的兽医医院之一Animal Health Partners建立了战略分销合作伙伴关系。我们明确了我们的价值主张，即提供一种设备，为兽医医疗保健中不受控制的癫痫发作提供唯一解决方案。我们已确定难治性犬癫痫细分市场为我们的主要目标。我们请求聘请专业顾问服务的目的是验证和扩大我们的初步市场评估。

We have developed ANIMO, the Adaptive Neural Implant for Modulation and Observation. ANIMO is a vessel to implant our proprietary machine learning and neuromodulation technology within the nervous system to interpret neural activity and to respond using electrical neurostimulation. We aim to deploy ANIMO as the solution for uncontrolled seizures in veterinary healthcare. The device is suitable for over 2.5 million drug-refractory candidates, and with an anticipated procedure cost of $10,000, a multi-billion-dollar potential market exists. When just considering insured cases of drug-refractory epilepsy alone (estimated to be about 2.5% of cases), the potential addressable market size is $720M. We have formed a strategic distribution partnership with one of the most advanced veterinary hospitals in Canada, Animal Health Partners.We have clarified our value proposition as providing a device which offers the only solution for uncontrolled seizures in veterinary healthcare. We have identified the drug-refractory canine epilepsy market segment as our primary target. The purpose of our request for enlist professional consultant services to validate and expand on our preliminary market assessment.